unresponsive to supportive treatments, including CPR and vasopressor therapy, LE administration can be considered. The suggested dosing regimen is as follows: 1) an initial intravenous bolus administration of 20% LE (1.5 mL/kg) is followed by a continuous infusion of 20% LE (0.25 mL/kg/min); and 2) when hemodynamic functions are unstable after the initial LE infusion, an intravenous administration of 20% LE (1.5 mL/kg) is repeated and followed by an increased continuous infusion of 20% LE (0.5 mL/kg/min). Further research is warranted regarding other possible mechanisms of LE's effect, the timing of LE administration, and the effect of various fatty acids on the LE-mediated reversal of cardiac arrest. This article reviews case reports and experimental evidence concerning the LE-mediated reversal of intractable cardiac arrest induced by drug toxicity, the underlying mechanism, and the dosing regimen.
Consider administering at the first signs of LAST, after airway management. Dosing: 1.5 mL/kg 20% lipid emulsion bolus 0.25 mL/kg per minute of infusion, continued for at least 10 mins after circulatory stability is attained If circulatory stability is not attained, consider rebolus and increasing infusion to 0.5 mL/kg per minute Approximately 10 mL/kg lipid emulsion for 30 mins is recommended as the upper limit for initial dosing Propofol is not a substitute for lipid emulsion (III; C). Failure to respond to lipid emulsion and vasopressor therapy should prompt institution of cardiopulmonary bypass (CPB) (IIa; B). Because there can be considerable lag in beginning CPB, it is reasonable to notify the closest facility capable of providing it when CV compromise is first identified during an episode of LAST The class of recommendation and level of evidence for each intervention are given in parenthesis (Table 2) . Ju-Tae Sohn, http://orcid.org/0000-0003-0102-5800 
